Wednesday, January 24th, 2007
15:00 M. van Sambeek - Evidence based indications for carotid revascularisations
15:40 J. Balzer - Are non-invasive techniques valuable for planning revascularization strategies?
16:40 D. Nikas - Carotid Access in Difficult Anatomical Situations D. Nikas
16:50 O. Mendiz - Concepts for Neuro-Protection During CAS: Which System for Which Lesion?
17:25 G. Biamino - Comparison of Different Neuro-protection Concepts: a Review of the Data
17:35 A. Cremonesi - Implications for stent choice during CAS
18:10 H. Sievert - Predictors of Complications During Carotid Stenting - Things to Avoid
18:20 G. Schroth - Timing and therapeutic strategies in acute carotid syndroms
Thursday, January 25th, 2007
08:25 W. Gray - Treatment of aorto-iliac TASC C and D lesions: techniques and results
08:35 C. Tiefenbacher - Stenotic lesions of the hypogastric artery (internal iliac artery) - when to treat
09:05 P. Peeters - Stenting in the SFA A review of data
09:45 S. Müller-Hülsbeck - New stent designs and materials
10:30 M. Schillinger - Primary stenting is the treatment of choice
10:45 T. Pfeiffer - Surgery is the most durable solution
11:00 I. Baumgartner - Complex SFA lesions should primarily be treated conservatively
11:00 U. Hoffmann - SFA lesions should primarily be treated conservatively
11:00 H. Krankenberg - Treatment of complex femoropopliteal obstructions Comment on
M. Schillinger: “Primary Stenting is the Treatment of Choice”
11:20 R. Waksman - Future Developments in Endovascullar Therapy
12:35 J. Balzer - Cryoplasty in PAOD – indications, techniques, and results
12:45 T. Zeller - The Impact of Renal Revascularisation on Cardiac Function
13:15 G. Tepe Disease Patterns and Treatment Options for Diabetic Patients with Femoro-Popliteal Disease
13:25 D. Scheinert - The Role of DES for Limb Salvage in Diabetic Patients
14:05 H. Mudra - Stroke prevention by carotid stenting – do diabetic patients benefit?
14:50 T. Collins - Obstructive Renal Artery Disease and Diabetic Nephropathy
Is there an indication for interventional treatment?
15:20 R. Langhoff - Best Treatment for CLI Patients
15:30 M. Bosiers - Laser recanalization for treatment of Critical Limb Ischemia
16:10 R. Waksman - Absorbable Metal Stent, Clinical Update and Unanswered Issues
16:45 G. Schuler - Treatment of Aortic Valve Disease: The Future is Percutaneous Aortic Valve Repair
16:55 Th. Walther - Treatment of aortic valve disease: Minimally invasive surgical techniques are save and effective
17:05 W. Gray - New concepts of rotational atherectomy in the peripheral arteries: The Pathway system
18:15 G. Schuler - How Should we Manage Significant Carotid Stenoses in Patients Undergoing CABG?
18:25 P. Pieniazek - Risk reduction with proximal neuroprotection by flow reversal or blockade in high - risk carotid artery stenting
19:30 A. Cremonesi - The role of standardized techniques and training for CAS
19:45 J. Balzer - Statistical evaluation of SPACE and EVA-3S study
20:00 K. Mathias - Quo vadis CAS?
12:30 E. Wedell - Complications session – Great Saves and Big Disasters –
Subclavian Artery Recanalisation: A standard procedure turning into a nightmare
12:50 D.-D. Do - Delayed rupture of the hypogastric artery: An unusual complication after PTA
13:00 F. Mahler - Painful dissections (?) in femoro-popliteal Intervention
13:10 A. Schwindt - Acute thrombus formation during CAS procedure, a severe SAE with happy ending
13:30 W. Ritter - Abdominal Aortic Aneurysma
Friday, January 26th, 2007
08:25 C. Rabbia - PTA and stenting of splancnic arteries C. Rabbia
08:35 T. Zeller - Evidence for Renal Artery Stenting: Did we make any progress?
08:45 G. Danzi - Same size, different arteries: coronary and tibial
09:25 M. Fusaro - Diabetic Foot and Claudication: What are the Differences in Pahtology?
09:35 M. Brodmann - Diabetic foot and Claudication – Differences in Treatment
10:30 C. Walker - Interventional Revascularization should be applied as first line therapy
10:45 I. Ruckert - Surgical options are most beneficial to save legs
11:00 K. Amendt - How can we effectively reduce amputation rates in patients with CLI ? Adjunctive medication and wound care is of key importance
11:00 P. Dahl - Adjunctive medication and wound care is of key importance
11:00 P. Peeters - Interventional revascularisation should be applied as first-line therapy
11:00 F. Vermassen - Surgical options are most beneficial to save legs
11:20 G. Biamino - BIODEGRADABLE PERIPHERAL IGAKI-TAMAI STENTS „PERSEUS“ STUDIES
11:30 C. Walker - New Self-Expanding Stent Concepts – the IDEV- Supera Stent
12:20 A. Schmidt - Subintimal Recanalization using CTO-Devices
12:30 S. Duda - How to Optimize Long-Term Outcome in the SFA
12:30 M. Schillinger - How to optimize long term outcome after SFA Stenting
13:00 G. Tepe - Thrombolysis versus Surgical Thrombectomy – A Critical Review
13:40 M. Husmann - Clinical experience with mechanical thrombectomy – intermediate resultsof the METHRO registry
13:50 N. Kucher - The Role of Optimal Anticoagulation during Treatment of Acute Thrombotic Occlusions
14:35 S. Müller-Hülsbeck - Large vessel thrombosis – what is the optimal treatment strategy?
15:10 M. Bosiers - Stent design closed cells vs open cells
15:20 A. Cremonesi - Carotid stenting: too old over 75?
16:55 A. Cremonesi - Carotid artery stenting can largely replace other treatment options
17:10 D. Raithel - Surgery is still the gold standard for the majority of the case
17:25 H. Koennecke - Revascularization is rarely indicated at all PRO
17:25 B. Reimers - Carotid artery stenting has largely replaced other treatment options
18:00 P. Dahl - CAROTID - RECONSTRUCTIONS
18:45 G. Schroth - Techniques and results of interventions in the vertebrobasilar system
18:55 T. Collins - Interventional Treatment of Intracranial Stenoses
Saturday, January 27th, 2007
08:55 M. van Sambeek - Who should undergo EVAR: Reflections from EVAR and DREAM Trial
09:05 P. Cao - Management of small AAA
09:15 J. Brunkwall - Acute type B aortic dissection-ready for a prime time?
09:55 R. Scharrer-Pamler - Traumatic aortic rupture
10:05 M. Makaroun - Late Results of Endovascular Treatment of Thoracic Aortic Aneurysms Compared to Open Repair
10:45 H. Krankenberg - Lessons Learnt from the FAST Study
10:55 G. Biamino - RESILIENT Trial
11:05 T. Zeller - Local Taxan with short time exposure for reduction of restenosis in distal arteries; 6 – month data – THUNDER Trial
11:15 T. Zeller - PRECISION Study Demographics and 6-Month Results
11:30 S. Müller-Hülsbeck - Stent Selection for the SFA: Are there any Differences?
12:00 E. Pilger - Stenting of the PA – a don’t ?
12:30 E. Kaiser - Basic requirements and integrated programmes for training in peripheral interventions
13:50 M. Siegenthaler - Hybrid treatment of thoracoabdominal aortic aneurysms
14:00 L. Qu - Technical challenges & solutions for endovascular treatment of complicated type-B aortic dissections